Sullivan SD - Search Results

1

International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study.

Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, Jensen RL, Marks GB, Gulsvik A, Nizankowska-Mogilnicka E; BOLD Collaborative Research Group. Buist AS, et al. Among authors: sullivan sd. Lancet. 2007 Sep 1;370(9589):741-50. doi: 10.1016/S0140-6736(07)61377-4. Lancet. 2007. PMID: 17765523

2

The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design.

Buist AS, Vollmer WM, Sullivan SD, Weiss KB, Lee TA, Menezes AM, Crapo RO, Jensen RL, Burney PG. Buist AS, et al. Among authors: sullivan sd. COPD. 2005 Jun;2(2):277-83. COPD. 2005. PMID: 17136954 Review.

3

Present and future costs of COPD in Iceland and Norway: results from the BOLD study.

Nielsen R, Johannessen A, Benediktsdottir B, Gislason T, Buist AS, Gulsvik A, Sullivan SD, Lee TA. Nielsen R, et al. Among authors: sullivan sd. Eur Respir J. 2009 Oct;34(4):850-7. doi: 10.1183/09031936.00166108. Epub 2009 Apr 8. Eur Respir J. 2009. PMID: 19357148 Free PMC article.

4

Case-finding options for COPD: results from the Burden of Obstructive Lung Disease study.

Jithoo A, Enright PL, Burney P, Buist AS, Bateman ED, Tan WC, Studnicka M, Mejza F, Gillespie S, Vollmer WM; BOLD Collaborative Research Group. Jithoo A, et al. Eur Respir J. 2013 Mar;41(3):548-55. doi: 10.1183/09031936.00132011. Epub 2012 Jun 27. Eur Respir J. 2013. PMID: 22743668 Free PMC article.

5

Cost-effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease.

Lee TA, Weiss KB, Sullivan SD. Lee TA, et al. Among authors: sullivan sd. Am J Med. 2004 Oct 15;117(8):618; author reply 618-9. doi: 10.1016/j.amjmed.2004.05.021. Am J Med. 2004. PMID: 15465515 No abstract available.

6

Cardiovascular events associated with ipratropium bromide in COPD.

Ogale SS, Lee TA, Au DH, Boudreau DM, Sullivan SD. Ogale SS, et al. Among authors: sullivan sd. Chest. 2010 Jan;137(1):13-9. doi: 10.1378/chest.08-2367. Epub 2009 Apr 10. Chest. 2010. PMID: 19363211

7

The economic costs of asthma: a review and conceptual model.

Weiss KB, Sullivan SD. Weiss KB, et al. Among authors: sullivan sd. Pharmacoeconomics. 1993 Jul;4(1):14-30. doi: 10.2165/00019053-199304010-00004. Pharmacoeconomics. 1993. PMID: 10146965 Review.

8

The economic burden of COPD.

Sullivan SD, Ramsey SD, Lee TA. Sullivan SD, et al. Chest. 2000 Feb;117(2 Suppl):5S-9S. doi: 10.1378/chest.117.2_suppl.5s. Chest. 2000. PMID: 10673466

9

Health outcomes assessment and economic evaluation in COPD: challenges and opportunities.

Sullivan SD, Buist AS, Weiss K. Sullivan SD, et al. Eur Respir J Suppl. 2003 Jun;41:1s-3s. doi: 10.1183/09031936.03.00077603. Eur Respir J Suppl. 2003. PMID: 12795325 Free article. No abstract available.

10

Socio-economic burden of asthma, allergy, and other atopic illnesses.

Weiss KB, Sullivan SD. Weiss KB, et al. Among authors: sullivan sd. Pediatr Allergy Immunol. 1994;5(6 Suppl):7-12. doi: 10.1111/j.1399-3038.1994.tb00341.x. Pediatr Allergy Immunol. 1994. PMID: 7728232

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

428 results

Search Page

Filters